Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dual-subtype FIV vaccine (Fel-O-Vax® FIV) protection against a heterologous subtype B FIV isolate

8 Jan 2005

Abstract excerpt

Vaccine trials were undertaken to determine whether the Fel-O-Vax FIV, a commercial dual-subtype (subtypes A and D) feline immunodeficiency virus (FIV) vaccine, is effective against a subtype B FIV isolate. Current results demonstrate the Fel-O-Vax FIV to be effective against a subtype B virus, a subtype reported to be the most common in the USA.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to HIV Research and Treatment
Share to Virology and Viral Diseases
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15686976
DOI: 10.1016/j.jfms.2004.08.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dual-subtype FIV vaccine (Fel-O-Vax® FIV) protection against a heterologous subtype B FIV isolatePMID 15686976Read ↗

Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected catsSemantic proximity Read ↗

Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolatesSemantic proximity Read ↗

Sequence variation of the feline immunodeficiency virus genome and its clinical relevance.Semantic proximity Read ↗

Immunogenicity of an anti-clade B feline immunodeficiency fixed-cell virus vaccine in field cats.Semantic proximity Read ↗

Identification of a novel subtype of feline immunodeficiency virus in a population of naturally infected felines in the Brazilian Federal District.Semantic proximity Read ↗

A detailed phylogenetic analysis of FIV in the United States.Semantic proximity Read ↗

Phylogenetic analysis suggests independent introduction of feline immunodeficiency virus clades A and B to Central Europe and identifies diverse variants of clade B.Semantic proximity Read ↗

Phylogenetic characterisation of feline immunodeficiency virus in naturally infected cats in Croatia indicates additional heterogeneity of subtype B in Europe.Semantic proximity Read ↗

Feline immunodeficiency virus subtypes A, B and C and intersubtype recombinants in Ontario, CanadaSemantic proximity Read ↗

Cross virus neutralizing antibodies against feline immunodeficiency virus genotypes A, B, C, D and E.Semantic proximity Read ↗

Lessons from the cat: development of vaccines against lentiviruses.Semantic proximity Read ↗

Cats are protected against feline immunodeficiency virus infection following vaccination with a homologous AP-1 binding site-deleted mutant.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.